tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Seres Therapeutics Inc. (DE:1S9)
:1S9
Germany Market
1S9
Seres Therapeutics
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Chart
Earnings
Historical Prices
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Seres Therapeutics (1S9) Stock News & Sentiment

Compare
1 Followers
Promising Developments and Financial Backing Bolster Seres Therapeutics’ Buy Rating
Premium
Ratings
Promising Developments and Financial Backing Bolster Seres Therapeutics’ Buy Rating
17d ago
MCRB
Seres Therapeutics Advances SER-155 Program with FDA Support
Premium
Company Announcements
Seres Therapeutics Advances SER-155 Program with FDA Support
17d ago
MCRB
Seres Therapeutics Earnings Call: Progress Amid Uncertainty
Premium
Company Announcements
Seres Therapeutics Earnings Call: Progress Amid Uncertainty
17d ago
MCRB
Seres Therapeutics: Strategic Developments and Promising Clinical Data Justify Buy Rating
Premium
Ratings
Seres Therapeutics: Strategic Developments and Promising Clinical Data Justify Buy Rating
18d ago
MCRB
Seres Therapeutics Reports 2024 Financial Results and SER-155 Progress
Premium
Company Announcements
Seres Therapeutics Reports 2024 Financial Results and SER-155 Progress
18d ago
8K
MCRB
Positive Outlook for Seres Therapeutics: FDA Endorsement and Strategic Study Design Boost Buy Rating
Premium
Ratings
Positive Outlook for Seres Therapeutics: FDA Endorsement and Strategic Study Design Boost Buy Rating
27d ago
MCRB
Seres Therapeutics Announces CMO Resignation in March 2025
Premium
Company Announcements
Seres Therapeutics Announces CMO Resignation in March 2025
1M ago
8K
MCRB
More DE:1S9 News >

1S9 News on the Web

Seres Therapeutics Inc (MCRB) Q4 2024 Earnings Call Highlights: Financial Improvements and ...
GuruFocus News
Neutral
Q4 2024 Seres Therapeutics Inc Earnings Call Transcript
GuruFocus News
Neutral
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant Development Approach
Yahoo Finance
Neutral
Seres’ SER-155 gains breakthrough status for BSIs reduction
Pharmaceutical Technology
Bullish
Seres Therapeutics (MCRB) Gets a Buy from TD Cowen
TipRanks News
Bullish
Seres Therapeutics: Q3 Earnings Snapshot
Yahoo Finance
Neutral
Institutions along with retail investors who hold considerable shares inSeres Therapeutics, Inc. come under pressure; lose 12% of holdings value
Yahoo Finance
Neutral
Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
DE:1S9
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:1S9’s Media Buzz Sentiment?
Currently, no data Available
What is DE:1S9’s weekly average amount of articles?
Currently, no data Available
What is DE:1S9’s News Sentiment?
59% of articles about DE:1S9 were positive this week, compared to its sector average of 60%.
    Healthcare Stocks that are Trending in the News
    ALCAlcon
    SLNOSoleno Therapeutics
    DYAIDyadic International
    CLGNCollplant Holdings
    OCXOncoCyte
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing